Sign In
Buy ANIK
$14.41
+0.0300 (+0.209%)
At Close: Jun 03, 2026
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
09:00am, Friday, 25'th Apr 2025
BEDFORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue it
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Monday, 07'th Apr 2025
BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis (“OA”) Pain Management and Regenerative Solutions space focused
Anika Therapeutics, Inc. (ANIK) Q4 2024 Earnings Call Transcript
05:55pm, Wednesday, 12'th Mar 2025
Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q4 2024 Earnings Conference Call March 12, 2025 5:00 PM ET Company Participants Matt Hall - Director, Corporate Development & Investor Relations Cheryl Blanchar
Anika Reports Fourth Quarter and Full Year 2024 Financial Results
04:05pm, Wednesday, 12'th Mar 2025
Full Year 2024 results in line with guidance with Commercial Channel revenue up 17% Strong International OA Pain Management and greater than 40% sequential growth of Integrity™ Implant System drive
Anika Completes Divestiture of Parcus Medical
06:00am, Friday, 07'th Mar 2025
Execution of Previously Announced Plan Sharpens Focus on Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio Execution of Previously Announced Plan Sharpens Focu
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025
08:00am, Wednesday, 26'th Feb 2025
BEDFORD, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
08:00am, Tuesday, 25'th Feb 2025
BEDFORD, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanch
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference
04:01pm, Monday, 23'rd Dec 2024
BEDFORD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanch
Anika To Participate in December 2024 Investor Conferences
04:16pm, Friday, 22'nd Nov 2024
BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior management
New Strong Sell Stocks for November 11th
02:31am, Monday, 11'th Nov 2024
AMRK, ANIK and ALG have been added to the Zacks Rank #5 (Strong Sell) List on November 11, 2024.
Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call Transcript
09:41pm, Saturday, 02'nd Nov 2024
Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Matt Hall - Director, Corporate Development and IR Cheryl Blanchard - Presiden
Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates
09:25am, Thursday, 31'st Oct 2024
Anika Therapeutics (ANIK) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of $0.30. This compares to loss of $0.45 per share a year ago.
Anika Reports Third Quarter 2024 Financial Results
07:05am, Thursday, 31'st Oct 2024
Updating 2024 fiscal year guidance to reflect announced changes to business strategy, including the sale of Arthrosurface and planned divestiture of Parcus Medical, and U.S. OA Pain Management headwin
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
07:00am, Thursday, 31'st Oct 2024
Company to Focus on Profitable Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio, Streamline Operations and Enhance Growth Profile Company to Focus on Profitab
Anika Announces Third Quarter 2024 Results Conference Call Date
04:01pm, Thursday, 17'th Oct 2024
BEDFORD, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its
